Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy

British Journal of Radiology

Volumn 84, Issue 1003, 2011, Pages 612-620

  Shin, H J ^a   Kim, Hak Hee ^a   Ahn, J H ^a   Kim, S B ^a   Jung, K H ^a   Gong, G ^a   Son, B H ^a   Ahn, S H ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 79959601520     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/74430952     Document Type: Article

References (38)

1. Bonadonna G, Valagussa P. Primary chemotherapy in operable breast cancer. Semin Oncol 1996;23:464-74. (Pubitemid 26277436)
2. Newman L, Buzdar A, Singletary S, Kuerer H, Buchholz T, Ames F, et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 2002;9:228-34. (Pubitemid 34298626)
3. Kuerer H, Singletary S, Buzdar A, Ames F, Valero V, Buchholz T, et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 2001;182:601-8. (Pubitemid 34142679)
4. Vlastos G, Mirza N, Lenert J, Hunt K, Ames F, Feig B, et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumour downstaging with induction chemotherapy. Cancer 2000;88:1417-24.
5. Booser D, Hortobagyi G. Treatment of locally advanced breast cancer. Semin Oncol 1992;19:278-85.
6. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher E, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85. (Pubitemid 28363030)
7. Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003;21:2600-8. (Pubitemid 46606344)
8. Kuerer H, Newman L, Buzdar A, Hunt K, Dhingra K, Buchholz T, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 1998;176:502-9. (Pubitemid 29056639)
9. Peintinger F, Kuerer H, Anderson K, Boughey J, Meric-Bernstam F, Singletary S, et al. Accuracy of the combination of mammography and sonography in predicting tumour response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 2006;13:1443-9. (Pubitemid 44749655)
10. Kwong M, Chung G, Horvath L, Ward B, Hsu A, Carter D, et al. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer. Cancer J 2006;12:212-21. (Pubitemid 43894338)
11. Singletary S, McNeese M, Hortobagyi G. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992;69:2849-52.
12. Segel M, Paulus D, Hortobagyi G. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169:49-54.
13. Swain S, Sorace R, Bagley C, Danforth DJ, Bader J, Wesley M, et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987;47:3889-94. (Pubitemid 17105745)
14. Herrada J, Iyer R, Atkinson E, Sneige N, Buzdar A, Hortobagyi G. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumour and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997;3:1565-9. (Pubitemid 27431564)
15. Weatherall P, Evans G, Metzger G, Saborrian M, Leitch A. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray mammography and palpation. J Magn Reson Imaging 2001;13:868-75. (Pubitemid 32479944)
16. Moskovic E, Mansi J, King D, Murch C, Smith I. Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 1993;47:339-44. (Pubitemid 23152721)
17. Vinnicombe S, MacVicar A, Guy R, Sloane J, Powles T, Knee G, et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996;198:333-40. (Pubitemid 26036832)
18. Gilles R, Guinebretiere J, Toussaint C, Spielman M, Rietjens M, Petit J, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-8. (Pubitemid 24177877)
19. Abraham D, Jones R, Jones S, Cheek J, Peters G, Knox S, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78:91-100. (Pubitemid 26189909)
20. Mumtaz H, Davidson T, Hall-Craggs M, Payley M, Walmsley K, Cowley G, et al. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg 1997;84:1147-51. (Pubitemid 27359498)
21. Rieber A, Zeitler H, Rosenthal H, Gorich J, Kreienberg R, Brambs H, et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997;70:452-8. (Pubitemid 27229264)
22. Drew P, Kerin M, Mahapatra T, Malone C, Monson J, Turnbull L, et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001;27:617-20. (Pubitemid 33062166)
23. Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002;72:145-52. (Pubitemid 34407209)
24. Partridge S, Gibbs J, Lu Y, Esserman L, Sudilovsky D, Hylton N. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002;179:1193-9. (Pubitemid 35204372)
25. Rosen E, Blackwell K, Baker J, Soo M, Bentley R, Yu D, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003;181:1275-82. (Pubitemid 37296403)
26. Partridge S, Gibbs J, Lu Y, Esserman L, Tripathy D, Wolverton D, et al. MRI measurements of breast tumour volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005;184:1774-81. (Pubitemid 40770147)
27. Yeh E, Slanetz P, Kopans D, Rafferty E, Georgian-Smith D, Moy L, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005;184:868-77. (Pubitemid 43899515)
28. Chen JH, Mehta RS, Nalcioglu O, Su MY. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol 2008;15:3609-13.
29. Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008;109:417-26. (Pubitemid 351692058)
30. Therasse P, Arbuck S, Eisenhauer E, Wanders J, Kaplan R, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
31. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-74. (Pubitemid 8131514)
32. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998;16:93-100. (Pubitemid 28041584)
33. Helvie M, Joynt L, Cody R, Pierce L, Adler D, Merajver S. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 1996;198:327-32. (Pubitemid 26036831)
34. Dershaw D, Drossman S, Liberman L, Abramson A. Assessment of response to therapy of primary breast cancer by mammography and physical examination. Cancer 1995;75:2093-8.
35. Chagpar A, Middleton L, Sahin A, Dempsey P, Buzdar A, Mirza A, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006;243:257-64. (Pubitemid 43185446)
36. Wasser K, Klein S, Fink C, Junkermann H, Sinn H, Zuna I, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 2003;13:80-7. (Pubitemid 36790494)
37. Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004;83:67-76. (Pubitemid 38141894)
38. Delille J, Slanetz P, Yeh E, Halpern E, Kopans D, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 2003;228:63-9. (Pubitemid 36736070)